Brought to you by 
Five Big Pharmas get nonexclusive rights to Ablexis mouse; added one more partner; and another
17 Jan 2019
Executive Summary
Pfizer Inc. and four other unnamed Big Pharma companies have received nonexclusive rights to use start-up Ablexis LLC's AlivaMab Mouse to discover antibodies.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Transgenics
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Five Big Pharmas get nonexclusive rights to Ablexis mouse; added one more partner; and another
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice